Background
Because
there is a lack of knowledge on the long-term consequences of maternal
morbidity/near miss episodes on women´s sexual life and function we conducted a
systematic review with the purpose of identifying the available evidence on any
sexual impairment associated with complications from pregnancy and childbirth.
Methods
Systematic
review on aspects of women sexual life after any maternal morbidity and/or
maternal near miss, during different time periods after delivery. The search
was carried out until May 22 nd ,
2015 including studies published from 1995 to 2015. No language or study design
restrictions were applied. Maternal morbidity as exposure was split into
general or severe/near miss. Female sexual outcomes evaluated were dyspareunia,
Female Sexual Function Index (FSFI) scores and time to resume sexual activity
after childbirth. Qualitative syntheses for outcomes were provided whenever
possible.
Results
A
total of 2,573 studies were initially identified, and 14 were included for
analysis after standard selection procedures for systematic review. General
morbidity was mainly related to major perineal injury (3 rd or 4 th degree
laceration, 12 studies). A clear pattern for severity evaluation of maternal
morbidity could not be distinguished, unless when a maternal near miss concept
was used. Women experiencing maternal morbidity had more frequently dyspareunia
and resumed sexual activity later, when compared to women without morbidity.
There were no differences in FSFI scores between groups. Meta-analysis could
not be performed, since included studies were too heterogeneous regarding study
design, evaluation of exposure and/or outcome and time span.
Conclusion
Investigation
of long-term repercussions on women’s sexual life aspects after maternal
morbidity has been scarcely performed, however indicating worse outcomes for
those experiencing morbidity. Further standardized evaluation of these
conditions among maternal morbidity survivors may provide relevant information
for clinical follow-up and reproductive planning for women.
Full article at: http://goo.gl/OXu1fc
By: Carla
B. Andreucci12, Jamile C. Bussadori2, Rodolfo C.
Pacagnella1, Doris Chou3,Veronique Filippi4, Lale Say3, Jose G. Cecatti1* and on behalf of the
Brazilian COMMAG Study Group and the WHO Maternal Morbidity Working Group
1Department of Obstetrics and Gynecology,
University of Campinas, Campinas, Brazil
2Federal University of Sao Carlos, Sao
Carlos, Brazil
3Reproductive Health Research unit, World
Health Organization, Geneva, Switzerland
4London School of Hygiene and Tropical
Medicine, University of London, London, England, UK
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment